万科企业(02202.HK)“17万科01”拟于7月18日付息
格隆汇7月12日丨万科企业(02202.HK)公告,万科企业股份有限公司2017年面向合格投资者公开发行公司债券(第一期)经中国证券监督管理委员会“证监许可[2015]1915号文”核准发行。期债券将于2019年7月18日支付2018年7月18日至2019年7月17日期间的利息。
“17万科01”的票面利率为4.50%,次付息每手(面值1,000元)债券派发利息人民币45.00元(含税)。扣税后个人、证券投资基金债券持有人取得的实际每手派发利息为36.00元;扣税后非居民企业(包含QFII、RQFII)取得的实际每手派发利息为45.00元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.